The effect of taurine on state of experimental gestosis in rats

Abstract

BACKGROUND: Gestosis (preeclampsia) is an important problem of modern obstetrics. Despite the improvement of methods of prevention and treatment, there is an increase in the rate of this pregnancy complication. In this regard, the search for new approaches to the treatment of preeclampsia is an important problem of modern perinatology.

AIM: The aim of this study is studying of the effect of taurine on experimental gestosis in rats.

MATERIALS AND METHODS: Preeclampsia was induced on female rats by sodium nitrite and lipopolysaccharide. 2-aminoethanesulfonic acid was administered at a dose of 44.3 mg / kg (in terms of taurine) from the 16^th to the 19^th day of pregnancy. The number of implantation sites, resorption sites, live fetuses, weight of placentas and fetuses, lactate dehydrogenase activity, content of lactic and pyruvic acids, nitric oxide, malondialdehyde and creatine were evaluated.

RESULTS: It has been shown that 2-aminoethanesulfonic acid leads to normalization of the metabolic processes (the level of malondialdehyde, nitric oxide, lactate and lactate dehydrogenase activity) in the body of pregnant female rats with induced preeclampsia in the last trimester of pregnancy. Taurine reduced the quantity of resorption, increased the weight of placentas and fetuses. Along with a correction of the lactate level, pyruvate and lactate dehydrogenase activity, it was observed a decrease of creatine level in placentas.

CONCLUSIONS: Obtained results allows us to recommend taurine, which has antioxidant, antihypoxic, membrane stabilizing, detoxifying, osmoregulating and diuretic effects, for the treatment of placental disorders with preeclampsia.

Keywords

rats / taurine / preeclampsia

References

[1] Aylamasyan EK. Gestoz: teoriya i praktika. Aylamasyan EK, Mozgovaya EV, eds. Moscow: MEDpress-inform; 2008. 271 p. (In Russ.)

[2] Айламазян Э.К. Гестоз: теория и практика / под ред. Э.К. Айламазян, Е.В. Мозговая. Москва: МЕДпресс-информ, 2008. 271 c.

[3] Mol BWJ, Thangaratinam S, Magee LA, et al. Pre-eclampsia. Lancet. 2016;10022(387):999–1011. DOI: 10.1016/SO140-6736 (15)00070-7

[4] Mol B.W.J., Thangaratinam S., Magee L.A., et al. Pre-eclampsia // Lancet. 2016. Vol. 387, No. 10022. P. 999–1011. DOI: 10.1016/SO140-6736 (15)00070-7

[5] Chen X, Andresen BT, Hill M, et al. Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Curr Hypertens. 2008;4(4):245–255. DOI: 10.2174/157340208786241336

[6] Chen X., Andresen B.T., Hill M., et al. Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction // Curr Hypertens. 2008. Vol. 4, No. 4. P. 245–255. DOI: 10.2174/157340208786241336

[7] Alfaidy N, Chauvet S, Andrei S, et al. Prion protein expression and functional importance in developmental angiogenesis: Role in oxidative stress and copper homeostasis. Antioxid Redox Signal. 2013;18(4):400–411. DOI: 10.1089/ars.2012.4637

[8] Alfaidy N., Chauvet S., Andrei S., et al. Prion protein expression and functional importance in developmental angiogenesis: Role in oxidative stress and copper homeostasis // Antioxid Redox Signal. 2013. Vol. 18, No. 4. P. 400–411. DOI: 10.1089/ars.2012.4637

[9] Akinshina SV, Bitsadze VO, Gadaeva ZK, et al. Trombotic microangiopathy in the pathogenesis of obstetric complications. Obstetrics, Gynecology and Reproduction. 2015;9(2):62–71. (In Russ.) DOI: 10.17749/2070-4968.2015.9.2.062-71

[10] Акиньшина С.В., Бицадзе В.О., Гадаева З.К., и др. Значение тромботической микроангиопатии в патогенезе акушерских осложнений // Акушерство, гинекология и репродукция. 2015. Т. 9, № 2. С. 62–71. DOI: 10.17749/2070-4968.2015.9.2.062-71

[11] Holwerda KM, Karumanchi SA, Lely AT. Hydrogen sulfide: Role in vascular physiology and pathology. Curr Opin Nephrol Hypertens. 2015;24(2):170–176. DOI: 10.1097/MNH.0000000000000096

[12] Holwerda K.M., Karumanchi S.A., Lely A.T. Hydrogen sulfide: Role in vascular physiology and pathology // Curr Opin Nephrol Hypertens. 2015. Vol. 24, No. 2. P. 170–176. DOI: 10.1097/MNH.0000000000000096

[13] Jiang Z, Zou Y, Ge Z, et al. A role of sFlt-1 in oxidative stress and apoptosis in human and mouse pre-eclamptic trophoblasts. Biol Reprod. 2015;93(3):73. DOI: 10.1095/biolreprod.114.126227

[14] Jiang Z., Zou Y., Ge Z., et al. A role of sFlt-1 in oxidative stress and apoptosis in human and mouse pre-eclamptic trophoblasts // Biol Reprod. 2015. Vol. 93, No. 3. P. 73. DOI: 10.1095/biolreprod.114.126227

[15] Levkovich MA, Plahotya TG, Berdichevskaya EM, et al. Summary peculiarities of cytokine regulation in chronic placental insufficiency. Modern Problems of Science and Education. 2016;(4):18. (In Russ.)

[16] Левкович М.А., Плахотя Т.Г., Бердичевская Е.М., и др. Особенности цитокиновой регуляции при хронической плацентарной недостаточности // Современные проблемы науки и образования. 2016. № 4. C. 18.

[17] Adu-Bonsaffoh K, Antwi DA, Gyan B, et al. Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women. BMC Physiol. 2017;17:5. DOI: 10.1186/s12899-017-0029-4

[18] Adu-Bonsaffoh K., Antwi D.A., Gyan B., et al. Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women // BMC Physiol. 2017. Vol. 17. P. 5. DOI: 10.1186/s12899-017-0029-4

[19] Perucci LO, Correa MD, Dusse LM, et al. Resolution of inflammation pathways in preeclampsia-a narrative review. Immunol Res. 2017;65(4):774–789. DOI: 10.1007/s12026-017-8921-3

[20] Perucci L.O., Correa M.D., Dusse L.M., et al. Resolution of inflammation pathways in preeclampsia-a narrative review // Immunol Res. 2017. Vol. 65, No. 4. P. 774–789. DOI: 10.1007/s12026-017-8921-3

[21] Hu TX, Guo X, Wang G, et al. MIR133b is involved in endogenous hydrogen sulfide suppression of sFlt-1 production in human placenta. Placenta. 2017;52:33–40. DOI: 10.1016/j.placenta.2017.02.012

[22] Hu T.X., Guo X., Wang G., et al. MIR133b is involved in endogenous hydrogen sulfide suppression of sFlt-1 production in human placenta // Placenta. 2017. Vol. 52. P. 33–40. DOI: 10.1016/j.placenta.2017.02.012

[23] Baczyk D, Audette MC, Coyaud E, et al. Spatiotemporal distribution of sumos during human placental development and in response to oxidative and inflammatory stress. J Physiol. 2018;596(9): 1587–1600. DOI: 10.1113/JP275288

[24] Baczyk D., Audette M.C., Coyaud E., et al. Spatiotemporal distribution of sumos during human placental development and in response to oxidative and inflammatory stress // J Physiol. 2018. Vol. 596, No. 9. P. 1587–1600. DOI: 10.1113/JP275288

[25] Aouache R, Biquard L, Vaiman D, et al. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19(5):1496. DOI: 10.3390/ijms19051496

[26] Aouache R., Biquard L., Vaiman D., et al. Oxidative stress in preeclampsia and placental diseases // Int J Mol Sci. 2018. Vol. 19, No. 5. P. 1496. DOI: 10.3390/ijms19051496

[27] Stojanovska V, Scherjon SA, Plösch T. Preeclampsia as modulator of offspring health. Biol Reprod. 2016;94(3):53. DOI: 10.1095/biolreprod.115.135780

[28] Stojanovska V., Scherjon S.A., Plösch T. Preeclampsia as modulator of offspring health // Biol Reprod. 2016. Vol. 94, No. 3. P. 53. DOI: 10.1095/biolreprod.115.135780

[29] Lin S, Leonard D, Co MA, et al. Pre-eclampsia has an adverse impact on maternal and fetal health. Transl Res. 2015;165(4): 449–463. DOI: 10.1016/j.trsl.2014.10.006

[30] Lin S., Leonard D., Co M.A., et al. Pre-eclampsia has an adverse impact on maternal and fetal health // Transl Res. 2015. Vol. 165, No. 4. P. 449–463. DOI: 10.1016/j.trsl.2014.10.006

[31] Wu CS, Nohr E, Bech BH, et al. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am J Obstet Gynecol. 2009;201(3):269.e1–269.e10. DOI: 10.1016/j.ajog.2009.06.060

[32] Wu C.S., Nohr E., Bech B.H., et al. Health of children born to mothers who had preeclampsia: a population-based cohort study // Am J Obstet Gynecol. 2009. Vol. 201, No. 3. P. 269.e1–269.e10. DOI: 10.1016 / j.ajog.2009.06.060

[33] Kiseleva NI, Zanko SN, Solodkov AP. Aktualnye problemy gestoza (patogenez, diagnostika, profilaktika i lechenie). Vitebsk: VSMU; 2007. 196 p. (In Russ.)

[34] Киселева Н.И., Занько С.Н., Солодков А.П. Актуальные проблемы гестоза (патогенез, диагностика, профилактика и лечение). Витебск: ВГМУ, 2007. 196 c.

[35] Gong P, Liu M, Hong G, et al. Curcumin improves LPS-induced preeclampsia-like phenotype in rat by inhibiting the TLR4 signaling pathway. Placenta. 2016;41:45–52. DOI: 10.1016/j.placenta.2016.03.002

[36] Gong P., Liu M., Hong G., et al. Curcumin improves LPS-induced preeclampsia-like phenotype in rat by inhibiting the TLR4 signaling pathway // Placenta. 2016. Vol. 41. P. 45–52. DOI: 10.1016/j.placenta.2016.03.002

[37] Hu J, Zhang J, Zhu B. Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol. 2019;33(6):649–658. DOI: 10.1111/fcp.12501

[38] Hu J., Zhang J., Zhu B. Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia // Fundam Clin Pharmacol. 2019. Vol. 33, No. 6. P. 649–658. DOI: 10.1111/fcp.12501

[39] Muzyko EA, Perfilova VN, Tyurenkov IN, et al. Effect of early and late pharmacological correction with GABA derivatives on cognitive disorders in offspring of rats with experimental preeclampsia. I.P. Pavlov Russian Medical Biological Herald. 2021;29(3):337–346. (In Russ.) DOI: 10.17816/PAVLOVJ61054

[40] Музыко Е.А., Перфилова В.Н., Тюренков И.Н., и др. Влияние ранней и поздней фармакологической коррекции производными ГАМК на когнитивные нарушения у потомства крыс с экспериментальной преэклампсией // Российский медико-биологический вестник имени академика И.П. Павлова. 2021. Т. 29, № 3. С. 337–346. DOI: DOI: 10.17816/PAVLOVJ61054

[41] Li G, Wei W, Suo L, Zhang C, et al. Low-dose aspirin prevents kidney damage in LPS-induced preeclampsia by inhibiting the WNT5A and NF-κB signaling pathways. Front Endocrinol (Lausanne). 2021;12:639592. DOI: 10.3389/fendo.2021.639592

[42] Li G., Wei W., Suo L., et al. Low-dose aspirin prevents kidney damage in LPS-induced preeclampsia by inhibiting the WNT5A and NF-κB signaling pathways // Front Endocrinol (Lausanne). 2021. Vol. 12. P. 639592. DOI: 10.3389/fendo.2021.639592

[43] Li Y, Liu Y, Chen J, Hu J. Protective effect of Fisetin on the lipopolysaccharide-induced preeclampsia-like rats. Hypertens Pregnancy. 2022;41(1):23–30. DOI: 10.1080/10641955.2021.2013874

[44] Li Y., Liu Y., Chen J., Hu J. Protective effect of Fisetin on the lipopolysaccharide-induced preeclampsia-like rats // Hypertens Pregnancy. 2022. Vol. 41, No. 1. P. 23–30. DOI: 10.1080/10641955.2021.2013874

[45] Abdelzaher WY, Mostafa-Hedeab G, Bahaa HA, et al. Leukotriene receptor antagonist, montelukast ameliorates L-NAME-induced pre-eclampsia in rats through suppressing the IL-6/Jak2/STAT3 signaling pathway. Pharmaceuticals (Basel). 2022;15(8):914. DOI: 10.3390/ph15080914settings

[46] Abdelzaher W.Y., Mostafa-Hedeab G., Bahaa H.A., et al. Leukotriene receptor antagonist, montelukast ameliorates L-NAME-induced pre-eclampsia in rats through suppressing the IL-6/Jak2/STAT3 signaling pathway // Pharmaceuticals (Basel). 2022. Vol. 15, No. 8. P. 914. DOI: 10.3390/ph15080914settings

[47] Tao X, Zhang Zh, Yang Zh, et al. The effects of taurine supplementation on diabetes mellitus in humans: A systematic review and meta-analysis. Food Chemistry: Molecular Sciences. 2022;4:100106. DOI: 10.1016/j.fochms.2022.100106

[48] Tao X., Zhang Zh., Yang Zh., et al. The effects of taurine supplementation on diabetes mellitus in humans: A systematic review and meta-analysis // Food Chemistry: Molecular Sciences. 2022. Vol. 4. P. 100106. DOI: 10.1016/j.fochms.2022.100106

[49] Bkaily Gh, Jazzar A, Normand A, et al. Taurine and cardiac disease: state of the art and perspectives. Can J Physiol Pharmacol. 2002;98(2):67–73. DOI: 10.1139/cjpp-2019-1313

[50] Bkaily Gh., Jazzar A., Normand A., et al. Taurine and cardiac disease: state of the art and perspectives // Can J Physiol Pharmacol. 2002. Vol. 98, No. 2. P. 67–73. DOI: 10.1139/cjpp-2019-1313

[51] Bae V, Ahmad K, Yin JE. Beneficial effects of taurine on metabolic parameters in animal and humans. J Obes metabol Syndr. 2022;31(2):134–146. DOI: 10.7570/jomes21088

[52] Bae V., Ahmad K., Yin JE. Beneficial effects of taurine on metabolic parameters in animal and humans // J Obes Metabol Syndr. 2022. Vol. 31, No. 2. P. 134–146. DOI: 10.7570/jomes21088

[53] Agökçeoğlu A, Yarim GF, Yarim M. The effects of taurine on central nervous system. Harran Üniv Vet Fak Derg. 2020;9(2):214–219. DOI: 10.31196/huvfd.75131

[54] Agökçeoğlu A., Yarim G.F., Yarim M. The effects of taurine on central nervous system // Harran Üniv Vet Fak Derg. 2020. Vol. 9, No. 2. P. 214–219. DOI:10.31196/huvfd.75131

[55] Castelli V, Paladini A, d’Angelo M, et al. Taurine and oxidative stress in retinal health and disease. CNS Neurosci Ther. 2021;27(4):403–412. DOI: 10.1111/cns.13610

[56] Castelli V., Paladini A., d’Angelo M., et al. Taurine and oxidative stress in retinal health and disease // CNS Neurosci Ther. 2021. Vol. 27, No. 4. P. 403–412. DOI: 10.1111/cns.13610

[57] Tochitani Sh. Taurine: a maternally derived nutrient linking mother and offspring. Metabolites. 2022;12(3):228. DOI: 10.3390/metabolo12030228

[58] Tochitani Sh. Taurine: a maternally derived nutrient linking mother and offspring // Metabolites. 2022. Vol. 12, No. 3. P. 228. DOI: 10.3390/metabolo12030228

[59] Shivananjappa MM, Muralidhara. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model. Reprod Biomed Online. 2012;24(5):558–566. DOI: 10.1016/j.rbmo.2012.01.016

[60] Shivananjappa M.M., Muralidhara. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model // Reprod Biomed Online. 2012. Vol. 24, No. 5. P. 558–566. DOI: 10.1016/j.rbmo.2012.01.016

[61] 31 Davydovskii A.G. Poisk sposobov korrektsii metabolicheskikh narushenii pri gestoze s pomoshchyu test-sistem in vitro (perspektivy test-tekhnologii). Meditsinskii Zhurnal. 2008;(4(26)):21–24. (In Russ.)

[62] Давыдовский А.Г. Поиск способов коррекции метаболических нарушений при гестозе с помощью тест-систем in vitro (перспективы тест-технологии) // Медицинский журнал. 2008. № 4(26). С. 21–24.

[63] Ellery SJ, Murthi P, Della Gatta PA, et al. The effects of early-onset pre-eclampsia on placental creatine metabolism in the third trimester. Int J Mol Sci. 2020;21(3):806. DOI: 10.3390/ijms21030806

[64] Ellery S.J., Murthi P., Della Gatta P.A., et al. The effects of early-onset pre-eclampsia on placental creatine metabolism in the third trimester // Int J Mol Sci. 2020. Vol. 21, No. 3. P. 806. DOI: 10.3390/ijms21030806

[65] Muccini AM, Tran NhT, Hale N, et al. The Effects of In Utero Fetal Hypoxia and Creatine Treatment on Mitochondrial Function in the Late Gestation Fetal Sheep Brain. Oxid Med Cell Longev.2022;3255296. DOI: 10.1155/2022/3255296

[66] Muccini A.M., Tran Nh.T., Hale N., et al. The Effects of In Utero Fetal Hypoxia and Creatine Treatment on Mitochondrial Function in the Late Gestation Fetal Sheep Brain // Oxid Med Cell Longev. 2022. Vol. 2022. P. 3255296. DOI: 10.1155/2022/3255296

[67] Schaffer S, Kim HW. Effects and mechanisms of taurine as a therapeutic agent. Biomol Ther (Seoul). 2018;26(3):225–241. DOI: 10.4062/biomolther.2017.251

[68] Schaffer S., Kim H.W. Effects and Mechanisms of Taurine as a Therapeutic Agent // Biomol Ther (Seoul). 2018. Vol. 26, No. 3. P. 225–241. DOI: 10.4062/biomolther.2017.251

RIGHTS & PERMISSIONS

ECO-vector LLC